This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Need for a New Framework to Understand the Mechanism of All Antipsychotics

Emmanuel Stip, Peter F. Liddle, and Jean Paul Soucy

Published: October 31, 2000

Article Abstract

Letter to the Editor

Sir: The advent of atypical neuroleptics has transformed the
pharmacologic treatment of schizophrenia. The advent of single
photon emission computed tomography (SPECT) and positron
emission tomography (PET) neuroreceptor imaging makes it
possible to link biochemical events in the human brain to their
clinical consequences. Remington and Kapur (supplement 10,
1999) have proposed an interesting model based on studies using
PET that takes in account the serotonin-2/dopamine-2
(5-HT2/D2) occupancy threshold: conventional antipsychotics
have low 5-HT2/high D2 ratios, olanzapine and risperidone have
high 5-HT2/high D2 ratios, clozapine has a high 5-HT2/low D2
ratio, and quetiapine has a low 5-HT2/low D2 ratio. Beyond
80% of D2 blockade, extrapyramidal symptoms appear. To attain
optimal blockade, 2 to 4 mg/day of a conventional neuroleptic
such as haloperidol is sufficient.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...